The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By

Colonial Enterprises, Inc.

Advising Brookfield Infrastructure Partners LLC on its acquisition of Colonial Enterprises, Inc., which owns and operates the Colonial Pipeline, the largest refined products system in the U.S., spanning ~5,500 miles between Texas and the New York Harbor

Dipsol Chemicals

Advising Quaker Houghton, a global leader in industrial process fluids, on the acquisition of Dipsol Chemicals, a leading supplier of surface treatment and plating solutions and services primarily for automotive and other industrial applications

Teijin Automotive Technologies – North America

Advising AURELIUS on the acquisition of Teijin Automotive Technologies (“TAT-NA”), the North American composites business being carved out from Japanese conglomerate Teijin Limited. TAT-NA is the leading North American player in advanced composite materials for the automotive, heavy truck, marine, and recreational vehicle sectors

UK High Street business of WH Smith PLC

Advising WH Smith PLC, one of the UK’s leading retailers, on the sale of its UK High Street business

Notified

Advising Equiniti Group, a Siris Capital Group portfolio company, on the acquisition of the Notified, a wholly owned subsidiary of West Technology Group., an Apollo Global Management portfolio company

Avail Infrastructure Solutions

Advised Avail Infrastructure Solutions on the sale of its Electrical Products Group, a leading provider of specialized products and solutions designed to support industrial and electrical applications, to nVent Electric plc (NYSE: NVT), a global leader in electrical connection and protection solutions

The Central Basin Platform assets of Lime Rock Resources IV, LP

Advised Ring Energy on its acquisition of the Central Basin Platform assets of Lime Rock Resources IV, LP

Innergex Renewable Energy Inc.

Advising the Special Committee of Innergex Renewable Energy Inc. on its sale to Caisse de dépôt et placement du Québec and provided fairness opinions in respect of the transaction to the common shareholders and the holders of the Series A preferred shares

Renewi plc

Advising Renewi plc, a leading European waste-to-product company, on its £707 million recommended cash offer for its entire issued share capital from a consortium controlled by Macquarie Asset Management and British Columbia Infrastructure Management Corporation (BCI)

Pacific Smiles Group

Advised Pacific Smiles Group Limited, one of Australia’s leading and fastest growing dental service organisations, on its response to multiple private equity proposals and ultimate sale to Genesis Capital by way of off-market takeover

PRISM Vision Group

Advising PRISM Vision Group, a leading medical eye care services company, on its majority stake sale to McKesson Corporation, a diversified healthcare services and distribution leader

The Container Store, Inc.

Advised the Ad Hoc Group of Term Loan Lender to The Container Store on its Pre Packaged Chapter 11 Restructuring

D-Wave Quantum

Advised D-Wave Quantum, a leader in quantum computing systems and services, on its $150mm at-the-market equity offering program

Techpoint

Advising Techpoint (TSE: 6697), a leading fabless semiconductor company developing high-definition video connectivity technology targeting automotive and security systems, on its $390M sale to ASMedia (TWSE: 5269), a fabless semiconductor company specializing in highspeed transmission interface IC design

Bullabulling Gold Project

Advising Minerals 260 on its purchase of the Bullabulling Gold Project from Norton Gold Fields (a wholly-owned subsidiary of one of the world’s largest gold producers, Zijin Mining Group)

Ranger Design

Advised Ranger Design on its sale to Clarience Technologies, a portfolio company of Genstar Capital

EMG Medallion Delaware Crude

Advising The Energy & Minerals Group on its Sale of Delaware Basin Crude Assets to Plains All American, a publicly traded master limited partnership which operates midstream energy infrastructure and provides logistics services for crude oil, natural gas liquids and natural gas

Ex-US rights to branded narcolepsy treatments, Provigil® (modafinil) and Nuvigil® (armodafinil)

Advised Neuraxpharm Group (“Neuraxpharm”), a leading European specialty pharmaceutical company, on the acquisition of the ex-US rights to Provigil® (modafinil) and Nuvigil® (armodafinil) from Teva Pharmaceuticals Industries Ltd. (“Teva”)

Renewable assets in Chile involving hybrid solar power generation and storage

Advised ContourGlobal (KKR) in the acquisition of 3 independent solar (Quillagua I & II, and Victor Jara) and BESS projects from Grenergy

Brigit

Advised Upbound Group, a technology and data-driven leader in accessible and inclusive financial products that address the evolving needs and aspirations of underserved consumers, on its acquisition of Brigit, a leading financial health technology company

Heartland Generation

Strategic advisor to Heartland Generation, one of Alberta's largest power generators and an Energy Capital Partners affiliate, on its sale to TransAlta Corporation

Empire Today

Advised Empire Today, the largest and only national DTC provider of replacement hard surface flooring and carpet in the U.S., on its liability management transaction

Robertet SA

Advising Fonds Stratégique de Participations and Peugeot Invest SA, on the acquisition of a 14% stake for €250 million in Robertet SA, world leader in natural products, from DSM-Firmenich AG

Blue Owl Technology Finance Corp. II (“OTF II”)

Advised and provided a fairness opinion to the Special Committee of the Independent Directors of OTF II, a specialty finance company focused on originating and making loans to, and making debt and equity investment in, technology related companies, specifically software, based primarily in the US, on its merger with OTF

Centogene GmbH

Advising Charme Capital Partners, a European mid-market private equity fund, on the acquisition of Centogene GmbH, a leading provider of pharmaceutical solutions and diagnostic tests for rare diseases